focus -WSS

focus

author：knowledge 2025-09-28 23:29:23 - browse：724

Novo Nordisk Denmark — LISELOTTE SABROE/AFP/Getty Images

An oral version of semaglutide, the drug marketed as Ozempic and Wegovy, led to dramatic weight loss in a trial enrolling people with obesity, manufacturer Novo Nordisk said Monday, data that could bolster what is already a blockbuster medicine.

In the study, which enrolled nearly 700 adults classified as having overweight or obesity, patients treated with a daily semaglutide tablet lost 15.1% of their body weight over the course of 17 months, while those on placebo lost 2.4%, Novo Nordisk said. The result is comparable to weekly injections of Wegovy, which in an earlier study led to 14.9% weight loss over the same period of time. In both studies, the most common side effects were gastrointestinal distress, with the majority of cases graded mild or moderate, the company said.

Novo Nordisk said it plans to submit oral semaglutide for U.S. and E.U. approvals later this year. A lower-dose version of the drug is already approved as a treatment for type 2 diabetes under the brand name Rybelsus.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： FDA approval of Sarepta Duchenne genetic therapy gives me hope
Next article： Close Medicare's dangerous gaps in addiction treatment coverage

WSS

'Ancient DNA,' 23andMe reveal African American ancestries

H5N1 bird flu found in pasteurized milk: what we know

Gilgo Beach: Police identify another victim in serial killing investigation

Q&A: Jennifer Adair on making gene therapy available globally

Nearly two

Bird flu outbreak in cows is latest avian flu curveball

focus

focus

hotspot

Cancer drug shortages should be causing more outrage

Bird flu in milk supply is likely coming from asymptomatic cows

Guidelines to prevent youth baseball injuries need more muscle

Cue Health's Covid

Drug repurposing or repositioning? The language matters

Microsoft strikes partnership with Duke Health to advance health AI

Bright Health sells Medicare Advantage business to Molina

Biden calls for immediate release of Niger's president amid apparent coup

Medical records are filled with copy

A cyberattack has disrupted hospitals and health care in several states

hotspot

2 US Navy sailors arrested for allegedly spying for China

MassMutual is introducing free genetic testing for members

CDC: Uninsured rate hit 'record low' right as states cut Medicaid

Attacks on the drug industry will lead to fewer breakthroughs

Influencer to be charged after chaos erupts in New York City's Union Square

Why rehabilitation engineers need to center patients in their research

hotspot

knowledge

hotspot

explore